TABLE I.
Demographic Data and Presenting Symptoms of Patients.
| Characteristics | COVID‐19 Group, n = 83 | Control Group, n = 60 | P Value |
|---|---|---|---|
| Male: female ratio | 48:35 | 26:34 | .087* |
| Age range, yr | 18–71 | 18–65 | |
| Mean age, yr | 36.4 ± 16.3 | 38.4 ± 14.2 | .305† |
| History of allergic rhinitis, no./total no. (%) | 16/83 (19.3) | 16/60 (35) | .295* |
| Medication for nasal symptoms, no./total no. (%) | 4/83 (4.8) | 6/60 (10) | .231 |
| History of nasal surgery, no./total no. | 0/83 | 0/60 | |
| Rhinorrhea, no./total no. (%) | 32/83 (38.6) | 27/60 (45) | .440* |
| Nasal blockage, no./total no. (%) | 31/83 (37.3) | 21/60 (35) | .773* |
| Purulent nasal discharge, no./total no. (%) | 3/83 (3.6) | 1/60 (1.67) | .486* |
| Epistaxis, no./total no. (%) | 5/83 (6.0) | 3/60 (5.0) | .793* |
| Cough, no./total no. (%) | 49/83 (59.0) | 28/60 (46.7) | .143* |
| Expectorant, no./total no. (%) | 34/83 (41.0) | 25/60 (41.7) | .933* |
| Dyspnea, no./total no. (%) | 18/83 (21.7) | 5/60 (8.3) | .032* |
| Subjective fever, no./total no. (%) | 43/83 (50.6) | 14/60 (23.3) | .001* |
| Documented fever on admission, no./total no. (%) | 23/83 (27.7) | 7/60 (13.2) | .020* |
| Smell change, no./total no. (%) | |||
| 1 (anosmia) | 18/83 (21.7) | 0/60 (0) | |
| 2–5 | 13/83 (15.7) | 0/60 (0) | |
| 6–9 | 8/83 (9.6) | 0/60 (0) | |
| 10 (normal) | 44/83 (53) | 60/60 (100) | <.001* |
| Taste change, no./total no. (%) | |||
| 1 (ageusia) | 7/83 (8.4) | 0/60 (0) | |
| 2–5 | 22/83 (26.5) | 0/60 (0) | |
| 6–9 | 7/83 (8.4) | 0/60 (0) | |
| 10 (normal) | 47/83 (56.6) | 60/60 (100) | <.001* |
*
Pearson χ2 test.
†
Mann‐Whitney U test.